Since there were only a few RAD51C methylation cases among the epigenetic HRD cases, it was difficult to compare their prognoses with those of the BRCA1 methylation cases (Supplementary Fig. 4A). This evidence concerns the gene RAD51C and hypoparathyroidism-retardation-dysmorphism syndrome.